Cost-utility analysis of empagliflozin for heart failure in the Philippines.
Montilla PJ, Aquino CO, Cunanan E, Encarnacion PJ, Ong-Garcia H, Llanes EJ, Orolfo DD, Permejo C, Taneo MJ, Villanueva AR, Salvador D Jr, Añonuevo J.
Montilla PJ, et al. Among authors: salvador d jr.
J Med Econ. 2025 Dec;28(1):157-167. doi: 10.1080/13696998.2024.2447180. Epub 2025 Jan 8.
J Med Econ. 2025.
PMID: 39743941
Free article.